Literature DB >> 28299724

Convection-Enhanced Delivery.

A M Mehta1, A M Sonabend1, J N Bruce2.   

Abstract

Convection-enhanced delivery (CED) is a promising technique that generates a pressure gradient at the tip of an infusion catheter to deliver therapeutics directly through the interstitial spaces of the central nervous system. It addresses and offers solutions to many limitations of conventional techniques, allowing for delivery past the blood-brain barrier in a targeted and safe manner that can achieve therapeutic drug concentrations. CED is a broadly applicable technique that can be used to deliver a variety of therapeutic compounds for a diversity of diseases, including malignant gliomas, Parkinson's disease, and Alzheimer's disease. While a number of technological advances have been made since its development in the early 1990s, clinical trials with CED have been largely unsuccessful, and have illuminated a number of parameters that still need to be addressed for successful clinical application. This review addresses the physical principles behind CED, limitations in the technique, as well as means to overcome these limitations, clinical trials that have been performed, and future developments.

Entities:  

Keywords:  Blood–brain barrier; Central nervous system; Convection-enhanced delivery; Drug delivery; Malignant gliomas; Technique

Mesh:

Year:  2017        PMID: 28299724      PMCID: PMC5398992          DOI: 10.1007/s13311-017-0520-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  124 in total

Review 1.  Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies.

Authors:  James L Frazier; James Lee; Ulrich W Thomale; Joseph C Noggle; Kenneth J Cohen; George I Jallo
Journal:  J Neurosurg Pediatr       Date:  2009-04       Impact factor: 2.375

2.  Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia.

Authors:  V G Johnson; C Wrobel; D Wilson; J Zovickian; L Greenfield; E H Oldfield; R Youle
Journal:  J Neurosurg       Date:  1989-02       Impact factor: 5.115

3.  Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction.

Authors:  R Prior; G Reifenberger; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Convection-enhanced delivery into the rat brainstem.

Authors:  David I Sandberg; Mark A Edgar; Mark M Souweidane
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

5.  High-flow microinfusion: tissue penetration and pharmacodynamics.

Authors:  P F Morrison; D W Laske; H Bobo; E H Oldfield; R L Dedrick
Journal:  Am J Physiol       Date:  1994-01

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors.

Authors:  Kim A Lopez; Aaron M Tannenbaum; Marcela C Assanah; Katy Linskey; Jonathan Yun; Alayar Kangarlu; Orlando D Gil; Peter Canoll; Jeffrey N Bruce
Journal:  Cancer Res       Date:  2011-04-04       Impact factor: 12.701

8.  Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma.

Authors:  H Liu; B S Jacobs; J Liu; R A Prayson; M L Estes; G H Barnett; B P Barna
Journal:  Cancer Immunol Immunother       Date:  2000-08       Impact factor: 6.968

9.  Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

Authors:  D M Lieberman; D W Laske; P F Morrison; K S Bankiewicz; E H Oldfield
Journal:  J Neurosurg       Date:  1995-06       Impact factor: 5.115

10.  Convection-enhanced delivery for targeted delivery of antiglioma agents: the translational experience.

Authors:  Jonathan Yun; Robert J Rothrock; Peter Canoll; Jeffrey N Bruce
Journal:  J Drug Deliv       Date:  2013-02-14
View more
  52 in total

1.  Focal, remote-controlled, chronic chemical modulation of brain microstructures.

Authors:  Khalil B Ramadi; Canan Dagdeviren; Kevin C Spencer; Pauline Joe; Max Cotler; Erin Rousseau; Carlos Nunez-Lopez; Ann M Graybiel; Robert Langer; Michael J Cima
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 2.  Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.

Authors:  Jana Miniarikova; Melvin M Evers; Pavlina Konstantinova
Journal:  Mol Ther       Date:  2018-02-08       Impact factor: 11.454

3.  Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.

Authors:  Michael J Castle; Fernando C Baltanás; Imre Kovacs; Alan H Nagahara; David Barba; Mark H Tuszynski
Journal:  Hum Gene Ther       Date:  2020-03-30       Impact factor: 5.695

Review 4.  Convection-enhanced drug delivery for glioblastoma: a review.

Authors:  Randy S D'Amico; Manish K Aghi; Michael A Vogelbaum; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

5.  Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

Authors:  Randy S D'Amico; Justin A Neira; Jonathan Yun; Nikita G Alexiades; Matei Banu; Zachary K Englander; Benjamin C Kennedy; Timothy H Ung; Robert J Rothrock; Alexander Romanov; Xiaotao Guo; Binsheng Zhao; Adam M Sonabend; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurosurg       Date:  2019-08-02       Impact factor: 5.115

6.  Magnetic Resonance Imaging-Guided Focused Ultrasound-Based Delivery of Radiolabeled Copper Nanoclusters to Diffuse Intrinsic Pontine Glioma.

Authors:  Xiaohui Zhang; Dezhuang Ye; Lihua Yang; Yimei Yue; Deborah Sultan; Christopher Pham Pacia; Hannah Pang; Lisa Detering; Gyu Seong Heo; Hannah Luehmann; Ankur Choksi; Abhishek Sethi; David D Limbrick; Oren J Becher; Yuan-Chuan Tai; Joshua B Rubin; Hong Chen; Yongjian Liu
Journal:  ACS Appl Nano Mater       Date:  2020-10-29

Review 7.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

Review 8.  Methods to measure, model and manipulate fluid flow in brain.

Authors:  Krishnashis Chatterjee; Cora M Carman-Esparza; Jennifer M Munson
Journal:  J Neurosci Methods       Date:  2019-12-12       Impact factor: 2.390

Review 9.  Current approaches to the management of brain metastases.

Authors:  John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang
Journal:  Nat Rev Clin Oncol       Date:  2020-02-20       Impact factor: 66.675

10.  Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.

Authors:  Julian S Rechberger; Erica A Power; Victor M Lu; Liang Zhang; Jann N Sarkaria; David J Daniels
Journal:  Neurosurg Focus       Date:  2020-01-01       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.